Laser Therapy Market Scope And Analysis

Laser Therapy Market Report Scope

Laser Therapy Market News and Recent Developments

The laser therapy market is evaluated by gathering qualitative and quantitative data post post-primary and secondary research, which includes important corporate publications, association data, and databases. The following is a list of developments in the market for laser therapy:

• Theralase Technologies Inc., a clinical-stage pharmaceutical company dedicated to the research and development of light and/or radiation-activated Photo Dynamic Compounds (“PDCs“) for the safe and effective destruction of various cancers, bacteria and viruses, donated two Theralase TLC-2400 Cool Laser Therapy (“CLT”) systems to the University of Windsor to aid in the research and development of a novel treatment for patients suffering from Parkinson’s Disease (“Parkinson’s”). (Theralase Technologies Inc., Press Release, 2024)
• ViaLase has secured approximately $40 million in Series C financing to drive the continued development of the company’s femtosecond laser for the treatment of glaucoma. The financing was led by a new investor and supported by current investors, including Venture Investors Health Fund, Arboretum Ventures, and Falcon Vision. (ViaLase, Inc., News, 2024)
• Norlase, leading global ophthalmic laser manufacturer developing next-generation laser solutions, announced it has closed its biggest investment round thus far. The US$ 11 million in funding was led by London-based firm West Hill Capital. The funding came on the heels of the FDA clearance and CE mark approval of the company’s most advanced product to date, the ECHO pattern laser. It enabled Norlase to accelerate the production ramp-up of the ECHO pattern laser, as well as its other cutting edge laser treatment solutions. (Norlase, News, 2023)
• ViaLase, Inc., a clinical-stage medical technology company focused on addressing unmet needs in the conventional glaucoma treatment paradigm, announced the enrollment of VIA-002, the company's pivotal trial of the ViaLase Laser to treat adult patients with primary open angle glaucoma (POAG). The ViaLase Laser combines the precision of femtosecond laser technology and the accuracy of micron-level image guidance to deliver a non-invasive glaucoma treatment called femtosecond laser image-guided high-precision trabeculotomy, or FLigHT. (ViaLase, Inc., News, 2023)

Laser Therapy Market Report Coverage and Deliverables

The “Laser TherapyMarket Size and Forecast (2021–2031)” report provides a detailed analysis of the market covering below areas:

• Market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
• Market dynamics such as drivers, restraints, and key opportunities
• Key future trends
• Detailed PEST/Porter’s Five Forces and SWOT analysis
• Global and regional market analysis covering key market trends, major players, regulations, and recent market developments
• Industry landscape and competition analysis covering market concentration, heat map analysis, prominent players, and recent developments
• Detailed company profiles